Industry Applications

Industrial Automation
Smart Home & IoT
Automotive & Transportation
Medical & Healthcare
Robotics & Drones
Consumer Electronics

JACS: Dual Active Cu Sites for Cascade Electrocatalytic C-N Coupling to Synthesize Amino Acids

by
JACS: Dual Active Cu Sites for Cascade Electrocatalytic C-N Coupling to Synthesize Amino Acids

Organic Electrocatalysis QQ Group: 692419836 Research Background Amino acids are the basic building blocks of living organisms and have wide applications in food, pharmaceuticals, and the chemical industry. Traditional methods for amino acid synthesis mainly include biological fermentation and chemical synthesis. While biological fermentation is environmentally friendly, it is costly and has a complex purification … Read more

Linux’s Gaming Experience Seems to Improve, Yet It Becomes a ‘Compatibility Layer’ for Windows

by
Linux's Gaming Experience Seems to Improve, Yet It Becomes a 'Compatibility Layer' for Windows

In the past few years, Linux has made incredible progress in the gaming field. Once a platform despised by gamers for its complexity and limited compatibility, it has now become a potential force to break Microsoft’s monopoly in the PC gaming sector. With the continuous investment from Proton, Bazzite, and the Linux user community, there … Read more

Phase II RCT of New ADC Brings Hope for R/R DLBCL Treatment

by
Phase II RCT of New ADC Brings Hope for R/R DLBCL Treatment

From May 30 to June 3, 2025, the largest global oncology conference, the American Society of Clinical Oncology (ASCO) Annual Meeting, was held in Chicago, USA. Researchers including Philippe Armand presented data from the waveLINE-003 Phase II study, exploring the recommended treatment dose, safety, and efficacy of the novel antibody-drug conjugate (ADC) Zilovertamab vedotin (ZV) … Read more

EHA/ICML Conference Highlights: Monoclonal Antibodies, Bispecific Antibodies, and ADCs Drive Efficient and Low-Toxicity Treatment Evolution for Lymphoma

by
EHA/ICML Conference Highlights: Monoclonal Antibodies, Bispecific Antibodies, and ADCs Drive Efficient and Low-Toxicity Treatment Evolution for Lymphoma

At the recent 2025 European Hematology Association (EHA) Annual Meeting and the International Conference on Malignant Lymphoma (ICML), not only were continuous breakthroughs in the field of lymphoma treatment witnessed, but a series of studies also validated the immense potential of precision immunotherapy in enhancing patient survival benefits. “Blood News” focuses on this international event, … Read more

ERICA Study: Preventing Nausea and Vomiting Associated with Novel HER2 ADC Treatment

by
ERICA Study: Preventing Nausea and Vomiting Associated with Novel HER2 ADC Treatment

Click the blue text above to follow us Editor’s Note: Novel HER2 antibody-drug conjugates (ADCs) have profoundly changed the clinical practice of breast cancer treatment, and managing their adverse reactions is a concern for clinicians. Although nausea and vomiting caused by novel HER2 ADCs in clinical trials are mostly mild adverse events, current international guidelines … Read more

Turning Dreams into Reality: Roche’s CD3 Bispecific Antibody Combined ADC Shows Exceptional Efficacy, Expanding the CD3 Bispecific ADC Concept

by
Turning Dreams into Reality: Roche's CD3 Bispecific Antibody Combined ADC Shows Exceptional Efficacy, Expanding the CD3 Bispecific ADC Concept

▎Trace Back Three years ago, when I wrote analyses on the CD3 bispecific antibody combined ADC, it was often considered an overly aggressive therapy. However, Roche has made significant explorations in this area. When the CD3/DLL3 ADC from Wuxi Biologics was released, many in the industry were puzzled, but there is no need for surprise. … Read more

MediLink Therapeutics: The Global Breakthrough Path of an ADC “Platform Player”

by
MediLink Therapeutics: The Global Breakthrough Path of an ADC "Platform Player"

Company Overview MediLink Therapeutics was founded in 2020, headquartered in Suzhou (with a research branch in Boston, USA), and has established research institutions in Shanghai and Singapore. The company’s founder, Dr. Xue Tongtong, previously served as the general manager of Kelun-Biotech and has over 10 years of experience in the research and management of antibodies, … Read more

New Champion in League of Legends – Yuna Appears! Ionia ADC Breaks Enemies with Beads and Ultimate Triple Strengthening

by
New Champion in League of Legends - Yuna Appears! Ionia ADC Breaks Enemies with Beads and Ultimate Triple Strengthening

Champion Background: The “Devout Goddess” in Seclusion for 200 Years Yuna is the guardian of the spiritual realm of Ionia, who, after two hundred years of seclusion, connects with the real world during the Spirit Blossom Festival. During Zhao Xin’s exploration of the spiritual realm, the two meet due to energy fluctuations, hinting at a … Read more

The Expanding ASIC Market: A Game Changer in Storage

by
The Expanding ASIC Market: A Game Changer in Storage

Introduction Recently, the ASIC market has seen a surge in popularity, especially in the storage sector, quietly transforming our industry landscape. Today, let’s discuss in simple terms why it is expanding so rapidly. Why is the ASIC Market Booming? Friends, you must have heard a lot about ASICs lately, right? Indeed, this market is genuinely … Read more

Telecommunications | Increased Investment in ASICs Accelerates AI Network Development

by
Telecommunications | Increased Investment in ASICs Accelerates AI Network Development

Written by｜Li Heran, Zhou Hanlin, Wei Pengcheng With the resonance of AI inference and training demands, along with the maturity of ASIC chips, the wave of AI network construction has been reignited. Major international chip leaders Marvell and Broadcom continue to increase their ASIC projects, suggesting that ASICs may drive the next wave of Capex … Read more